Qaytona is free while it's in beta — Get started

Ingredients

Okra

Abelmoschus esculentus · Lady's Finger · Bhindi

Snapshot

IndicationsContraindications
  • Type 2 diabetes glycemic control1–3
  • Dyslipidemia4
  • Body weight and body mass index1, 5–9
  • Liver enzyme levels5
  • Functional constipation (blend)10, 11
  • Meibomian gland dysfunction12
  • Demodex blepharitis13
  • Pregnancy and lactation14
  • Use in children14

Okra (Abelmoschus esculentus) is a mucilage-rich pod vegetable, also sold as extract or powder, that supplies fiber, calcium, iron, and zinc15. It is also used for functional constipation, as a blend with ashwagandha root, and as a topical eyelid patch for meibomian gland dysfunction and Demodex blepharitis. The typical patient is an adult with type 2 diabetes continuing standard therapy2.

In type 2 diabetes, one meta-analysis of randomized trials found lower fasting glucose and glycated hemoglobin. Another meta-analysis in pre-diabetes or type 2 diabetes found lower fasting glucose without a change in glycated hemoglobin1, 3. The constipation trials tested a proprietary okra and ashwagandha blend, not okra alone. In rats, a 2026 toxicology study of that blend found no toxicity or genotoxicity16. Products listing okra number 169 in the National Institutes of Health Dietary Supplement Label Database, mostly powders and capsules; see Form comparison.

A minority of United States product labels advise against use during pregnancy and lactation14. Per United States product labels, individuals taking medication are asked to discuss potential interactions with their healthcare professional14.

Last updated October 15, 2026. Read how we make monographs.

In the full monograph

45 sources, 39 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1The Impact of Okra (Abelmoschus esculentus) Supplementation on Diabetes and Obesity Biomarkers in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.pubmed.ncbi.nlm.nih.govFan, Wu, Zhang et al. · Phytotherapy research : PTR · 2025 · Pubmed
  2. 2Clinical efficacy and safety of okra (Abelmoschus esculentus (L.) Moench) in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial.pubmed.ncbi.nlm.nih.govTavakolizadeh, Peyrovi, Ghasemi-Moghaddam et al. · Acta diabetologica · 2023 · Pubmed
  3. 3Okra ameliorates hyperglycaemia in pre-diabetic and type 2 diabetic patients: A systematic review and meta-analysis of the clinical evidence.pubmed.ncbi.nlm.nih.govMokgalaboni, Lebelo, Modjadji et al. · Frontiers in pharmacology · 2023 · Pubmed
  4. 4Effect of Abelmoschus esculentus L. (Okra) on Dyslipidemia: Systematic Review and Meta-Analysis of Clinical Studies.pubmed.ncbi.nlm.nih.govMokgalaboni, Phoswa, Mokgalabone et al. · International journal of molecular sciences · 2024 · Pubmed
  5. 5Beneficial effects of okra (Abelmoschus esculentus L.) consumption on anthropometric measures, blood pressure, glycaemic control, lipid profile and liver function tests in randomised controlled trials: a GRADE-assessed systematic review and dose-response meta-analysis.pubmed.ncbi.nlm.nih.govJafari, Mardani, Parsi Nezhad et al. · The British journal of nutrition · 2025 · Pubmed
  6. 6Microbiota Composition and Diversity in Weight Loss Population After the Intake of IQP-AE-103 in a Double-Blind, Randomized, Placebo-Controlled Study.pubmed.ncbi.nlm.nih.govPeng, Cooper, De Costa et al. · Frontiers in nutrition · 2022 · Pubmed
  7. 7Clinical evidence for fat-binding-mediated fecal fat excretion by RODLTM (Red Okra-Diospyros lotus botanical combination) under a prescribed restricted diet: a randomized, double-blind, placebo-controlled trial.pubmed.ncbi.nlm.nih.govPark, Park, Kim · Food & nutrition research · 2026 · Pubmed
  8. 8The effect of okra (Abelmoschus esculentus) on lipid profiles and glycemic indices in Type 2 diabetic adults: Randomized double blinded trials.pubmed.ncbi.nlm.nih.govMoradi, Tarrahi, Ghasempour et al. · Phytotherapy research : PTR · 2020 · Pubmed
  9. 9The effect of Abelmoschus esculentus L. (Okra) extract supplementation on dietary intake, appetite, anthropometric measures, and body composition in patients with diabetic nephropathy.pubmed.ncbi.nlm.nih.govNikpayam, Safaei, Bahreyni et al. · Health promotion perspectives · 2022 · Pubmed
  10. 10A Novel Herbal Composition Alleviates Functional Constipation, Reduces Gastrointestinal Transit Time, and Improves Bowel Function in Adults: A Double-Blind, Randomized Clinical Study.pubmed.ncbi.nlm.nih.govSingh, Dixit, Kalman et al. · Journal of the American Nutrition Association · 2024 · Pubmed
  11. 11A blend of Withania somnifera (L.) Dunal root and Abelmoschus esculentus (L.) Moench fruit extracts relieves constipation and improves bowel function: A proof-of-concept clinical investigation.pubmed.ncbi.nlm.nih.govPunukollu, Chadalawada, Siddabattuni et al. · Journal of ethnopharmacology · 2024 · Pubmed
  12. 12Okra eyelid patch versus sodium hyaluronate combined with ofloxacin eye drop in the treatment of meibomian gland dysfunction: a randomized controlled trial.pubmed.ncbi.nlm.nih.govWu, Ma, Li et al. · BMC ophthalmology · 2026 · Pubmed
  13. 13Anti-demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil.pubmed.ncbi.nlm.nih.govLiu, Gong · Experimental and therapeutic medicine · 2021 · Pubmed
  14. 14US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm
  15. 15Proximate, mineral, and antinutrient compositions of indigenous Okra (Abelmoschus esculentus) pod accessions: implications for mineral bioavailability.pubmed.ncbi.nlm.nih.govGemede, Haki, Beyene et al. · Food science & nutrition · 2016 · Pubmed
  16. 16Toxicological Assessment of LN20188, a Botanical Combination of Withania somnifera Root and Abelmoschus esculentus Fruit Extracts.pubmed.ncbi.nlm.nih.govMadireddy, Dodda, Chinta et al. · BioMed research international · 2026 · Pubmed